Klingenstein Fields & CO LP Illumina, Inc. Transaction History

Klingenstein Fields & CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$181.58 - $368.0 $116,029 - $235,152	-639 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$372.84 - $481.5 $27,590 - $35,631	74 Added 13.1%	639 $302,000
Q1 2021 Apr 29, 2021	SELL	$361.28 - $504.76 $195,452 - $273,075	-541 Reduced 48.92%	565 $217,000
Q4 2020 Feb 02, 2021	BUY	$292.7 - $370.96 $64,394 - $81,611	220 Added 24.83%	1,106 $409,000
Q3 2020 Oct 30, 2020	SELL	$268.51 - $400.74 $3,759 - $5,610	-14 Reduced 1.56%	886 $274,000
Q1 2020 May 07, 2020	BUY	$209.2 - $335.53 $20,920 - $33,553	100 Added 12.5%	900 $246,000
Q2 2018 Jul 26, 2018	BUY	$228.17 - $292.07 $182,536 - $233,656	800 New	800 $223,000

967

151M

2.37M

1.41M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

Stay updated on Klingenstein Fields & CO LP with notifications on news.